GE HealthCare adds new clinical applications to airway imaging system

GE HealthCare adds new clinical applications to airway imaging system

GE HealthCare adds new clinical applications to airway imaging system

GE HealthCare has added several new functions to its OEC 3D C-arm portfolio to enhance clinician workflows and improve the visualisation of airways in the lungs during endoscopic bronchoscopy procedures.

For advanced imaging in endoscopic bronchoscopy, GE has introduced the OEC 3D Lung Suite. The platform provides augmented fluoroscopy overlays of 3D points of interest on live fluoroscopy images and adjustable motorised 3D scanning intended to account for patient or equipment movements during a scan.

Introduced in 2021, the OEC 3D C-arm is designed to provide 3D and 2D imaging without the need to switch systems during procedures. In June 2023, GE HealthCare signed an agreement with Johnson & Johnson’s orthopaedics company DePuy Synthes for the distribution of the system in the US.

GE HealthCare has also verified Intuitive Surgical’s Ion Endoluminal Robotic Bronchoscopy System to OEC Open. Currently verified with eight third-party systems, the interface allows clinicians to supplement the OEC 3D C-arm’s imaging capabilities with other technologies spanning robotics, navigation, and augmented reality vision.

The addition of Intuitive’s system to the interface means that clinicians can now automatically transfer OEC 3D mobile cone beam computed tomography (CBCT) images upon reconstruction to the Ion System to update target locations for clinician catheter adjustments during the procedure. 

Dr Dominique Pepper, medical director of bronchoscopy and respiratory care at Providence Swedish South Puget Sound, described the interface verification of the Ion Robotic Bronchoscopy System as a “gamechanger”.

Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free
sample

Your download email will arrive shortly

We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form

By GlobalData







Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“I believe we can now reach and diagnose almost any nodule in the lung,” said Pepper.

“GE HealthCare is excited about the addition of the Intuitive Ion robotic system to our OEC Open interface,” said GE HealthCare’s global general manager for surgery Christian O’Connor.

“This interface provides interventional pulmonologists using the OEC 3D C-arm a seamless experience during minimally invasive, robotic-assisted bronchoscopy procedures. Furthermore, this collaboration also signifies our continued commitment to enabling surgeons access to the latest technologies to support them in providing exceptional patient care.”

According to GlobalData analysis, the C-arm segment of the global diagnostic imaging market was valued at almost $2bn in 2023 and is forecast to reach a valuation of around $2.7bn by 2033.

In other recent developments, GE Healthcare received clearance earlier this month from the US Food and Drug Administration for its SIGNA MAGNUS MRI scanner. Last month, the company launched Versana Premier, the latest addition to its Versana family of ultrasound systems.



link

Leave a Reply

Your email address will not be published. Required fields are marked *